1 Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité - Universitätsmedizin Berlin, Germany (G.G.S.).
2 Translational Approaches in Heart Failure and Cardiometabolic Disease, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany (G.G.S.).
3 DZHK (German Centre for Cardiovascular Research), Berlin, Germany (G.G.S.).
4 Friede Springer Cardiovascular Prevention Center at Charité - Universitätsmedizin Berlin, Germany (G.G.S.).
5 Experimental and Clinical Research Center (ECRC), a Cooperation of Charité-Universitätsmedizin Berlin and Max Delbruck Center for Molecular Medicine (MDC), Berlin, Germany (G.G.S.).
6 Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy (G.G.S.).
7 Department of Biological Sciences and Translational Medicine, Masonic Medical Research Institute, Utica, NY (M.I.K.).
8 Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA (M.I.K.).
9 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA (M.I.K.).